Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Goodwill (2016 - 2021)

Assembly Biosciences has reported Goodwill over the past 7 years, most recently at $12.6 million for Q3 2021.

  • Quarterly results put Goodwill at $12.6 million for Q3 2021, changed 0.0% from a year ago — trailing twelve months through Sep 2021 was $12.6 million (changed 0.0% YoY), and the annual figure for FY2020 was $12.6 million, changed 0.0%.
  • Goodwill for Q3 2021 was $12.6 million at Assembly Biosciences, roughly flat from $12.6 million in the prior quarter.
  • Over the last five years, Goodwill for ASMB hit a ceiling of $12.6 million in Q1 2017 and a floor of $12.6 million in Q4 2017.
  • Median Goodwill over the past 5 years was $12.6 million (2017), compared with a mean of $12.6 million.
  • Peak annual rise in Goodwill hit 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
  • Assembly Biosciences' Goodwill stood at $12.6 million in 2017, then changed by 0.0% to $12.6 million in 2018, then changed by 0.0% to $12.6 million in 2019, then changed by 0.0% to $12.6 million in 2020, then changed by 0.0% to $12.6 million in 2021.
  • The last three reported values for Goodwill were $12.6 million (Q3 2021), $12.6 million (Q2 2021), and $12.6 million (Q1 2021) per Business Quant data.